PRESS RELEASE published on 11/04/2025 at 11:38, 10 months 23 days ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research initiates coverage on MaaT Pharma SACA with a BUY rating and EUR 17 price target. MaaT Pharma focuses on microbiome-based therapies for oncology, with high clinical impact and late-stage pipeline Oncology BUY Rating Clinical-stage Biotechnology MaaT Pharma SACA Microbiome-based Therapies
BRIEF published on 11/04/2025 at 07:35, 10 months 23 days ago MaaT Pharma Third Quarter 2025 Financial Results and Financing Update Financial Results MaaT Pharma European Medicines Agency Xervyteg® Clinigen Partnership
BRIEF published on 11/04/2025 at 07:35, 10 months 23 days ago MaaT Pharma : Résultats financiers et mise à jour du financement pour le troisième trimestre 2025 Résultats Financiers MaaT Pharma Agence Européenne Des Médicaments Xervyteg® Partenariat Clinigen
PRESS RELEASE published on 11/04/2025 at 07:30, 10 months 23 days ago Inside Information / News release on accounts, results MaaT Pharma reports Q3 2025 financial results, secured financing, and partnership updates. Cash position of €22.4 million. Revenues increased by 45% year-over-year Revenues Financing Partnership MaaT Pharma Q3 2025
PRESS RELEASE published on 11/04/2025 at 07:30, 10 months 23 days ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma annonce ses activités de financement et résultats financiers T3 2025, incluant un accord avec Clinigen augmentant le CA de 45% Résultats Financiers Croissance Financement MaaT Pharma Accord Clinigen
BRIEF published on 10/13/2025 at 14:52, 11 months 14 days ago Franchissement de Seuils par Invus Public Equities dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Invus Public Equities
BRIEF published on 10/13/2025 at 14:52, 11 months 14 days ago Crossing of Thresholds by Invus Public Equities in MAAT PHARMA Voting Rights Crossing Thresholds Transfer Of Shares MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/13/2025 at 14:47, 11 months 14 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities pour MAAT PHARMA avec 4,96% du capital et des droits de vote suite à une cession d'actions sur le marché Franchissement De Seuils Marché Cession D'actions MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/07/2025 at 07:30, 11 months 20 days ago Informations privilégiées / Autres communiqués
BRIEF published on 10/06/2025 at 14:59, 11 months 21 days ago Symbiosis LLC réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Symbiosis LLC
Published on 09/26/2026 at 01:00, 2 days ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 3 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 7 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 10 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 8 hours 14 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 9 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 9 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 10 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 17 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 7 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 7 hours ago Availability of the 2026 half-year financial report
